Amia Capital LLP Alnylam Pharmaceuticals, Inc. Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$122.97 - $147.0 $853,042 - $1.02 Million	-6,937 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $298,975 - $408,263	-2,467 Reduced 26.23%	6,937 $1.01 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $473,321 - $710,550	-4,542 Reduced 32.57%	9,404 $1.39 Million
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $368,475 - $530,198	-3,957 Reduced 22.1%	13,946 $1.52 Million
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $1.33 Million - $2.22 Million	17,903 New	17,903 $2.06 Million

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.